PubMed

Brimonidine purite 0.15% versus dorzolamide 2% each given twice daily to reduce intraocular pressure in subjects with open angle glaucoma or ocular hypertension.

Sharpe ED, Day DG, Beischel CJ, Rhodes JS, Stewart JA, Stewart WC.

Br J Ophthalmol. 2004 Jul;88(7):953-6.PMID: 15205246 [PubMed - indexed for MEDLINE]Related articlesFree article

24-hour intraocular pressures with brimonidine purite versus dorzolamide added to latanoprost in primary open-angle glaucoma subjects.

Konstas AG, Karabatsas CH, Lallos N, Georgiadis N, Kotsimpou A, Stewart JA, Stewart WC.

Ophthalmology. 2005 Apr;112(4):603-8.PMID: 15808251 [PubMed - indexed for MEDLINE]Related articles

Brimonidine 0.2% versus dorzolamide 2% each given three times daily to reduce intraocular pressure.

Stewart WC, Sharpe ED, Harbin TS Jr, Pastor SA, Day DG, Holmes KT, Stewart JA.

Am J Ophthalmol. 2000 Jun;129(6):723-7.PMID: 10926979 [PubMed - indexed for MEDLINE]Related articles

Comparison of the safety and efficacy of dorzolamide 2% and brimonidine 0.2% in patients with glaucoma or ocular hypertension.

Whitson JT, Henry C, Hughes B, Lee DA, Terry S, Fechtner RD.

J Glaucoma. 2004 Apr;13(2):168-73.PMID: 15097265 [PubMed - indexed for MEDLINE]Related articles

An eight-week, multicentric, randomized, interventional, open-label, phase 4, parallel comparison of the efficacy and tolerability of the fixed combination of timolol maleate 0.5%/brimonidine tartrate 0.2% versus fixed combination of timolol maleate 0.5%/dorzolamide 2% in patients with elevated intraocular pressure.

Hatanaka M, Grigera DE, Barbosa WL, Jordao M, Susanna R Jr.

J Glaucoma. 2008 Dec;17(8):674-9.PMID: 19092465 [PubMed - indexed for MEDLINE]Related articles

Efficacy of brimonidine 0.2% and dorzolamide 2% as adjunctive therapy to beta-blockers in adult patients with glaucoma or ocular hypertension.

Simmons ST; Alphagan/Trusopt Study Group.

Clin Ther. 2001 Apr;23(4):604-19.PMID: 11354394 [PubMed - indexed for MEDLINE]Related articles

Comparison of brimonidine with latanoprost in the adjunctive treatment of glaucoma. ALPHAGAN/XALATAN Study Group.

Simmons ST, Samuelson TW.

Clin Ther. 2000 Apr;22(4):388-99.PMID: 10823361 [PubMed - indexed for MEDLINE]Related articles

Dorzolamide/timolol combination versus concomitant administration of brimonidine and timolol: six-month comparison of efficacy and tolerability.

Sall KN, Greff LJ, Johnson-Pratt LR, DeLucca PT, Polis AB, Kolodny AH, Fletcher CA, Cassel DA, Boyle DR, Skobieranda F.

Ophthalmology. 2003 Mar;110(3):615-24.PMID: 12623832 [PubMed - indexed for MEDLINE]Related articles

Comparing the fixed combination brimonidine-timolol versus fixed combination dorzolamide-timolol in patients with elevated intraocular pressure.

Arcieri ES, Arcieri RS, Pereira AC, Andreo EG, Finotti IG, Sá Filho WF.

Curr Med Res Opin. 2007 Apr;23(4):683-9.PMID: 17407624 [PubMed - indexed for MEDLINE]Related articles

Unoprostone as adjunctive therapy to timolol: a double masked randomised study versus brimonidine and dorzolamide.

Hommer A, Kapik B, Shams N; Unoprostone Adjunctive Therapy Study Group.

Br J Ophthalmol. 2003 May;87(5):592-8.PMID: 12714402 [PubMed - indexed for MEDLINE]Related articlesFree article

Dorzolamide/Timolol fixed combination versus concomitant administration of brimonidine and timolol in patients with elevated intraocular pressure: a 3-month comparison of efficacy, tolerability, and patient-reported measures.

Solish AM, DeLucca PT, Cassel DA, Kolodny AH, Hustad CM, Skobieranda F.

J Glaucoma. 2004 Apr;13(2):149-57.PMID: 15097262 [PubMed - indexed for MEDLINE]Related articles

[Efficiency of brimonidine 0.2% and dorzolamide 2% as adjunctive therapy to beta-blockers]

Carrasco Font C, Arias Puente A, García Sáenz MC, Villarejo Díaz-Maroto I.

Arch Soc Esp Oftalmol. 2004 Apr;79(4):163-8. Spanish. PMID: 15124072 [PubMed - indexed for MEDLINE]Related articlesFree article

The efficacy and safety of latanoprost 0.005% once daily versus brimonidine 0.2% twice daily in open-angle glaucoma or ocular hypertension.

Stewart WC, Day DG, Stewart JA, Schuhr J, Latham KE.

Am J Ophthalmol. 2001 May;131(5):631-5.PMID: 11336939 [PubMed - indexed for MEDLINE]Related articles

Timolol 0.5%/dorzolamide 2% fixed combination vs timolol maleate 0.5% and unoprostone 0.15% given twice daily to patients with primary open-angle glaucoma or ocular hypertension.

Day DG, Schacknow PN, Wand M, Sharpe ED, Stewart JA, Leech J, Stewart WC.

Am J Ophthalmol. 2003 Feb;135(2):138-43.PMID: 12566015 [PubMed - indexed for MEDLINE]Related articles

Brimonidine-purite 0.1% versus brimonidine-purite 0.15% twice daily in glaucoma or ocular hypertension: a 12-month randomized trial.

Cantor LB, Safyan E, Liu CC, Batoosingh AL.

Curr Med Res Opin. 2008 Jul;24(7):2035-43. Epub 2008 Jun 4.PMID: 18534052 [PubMed - indexed for MEDLINE]Related articles

The safety and efficacy of unoprostone 0.15% versus brimonidine 0.2%.

Stewart WC, Stewart JA, Day DG, Jenkins J.

Acta Ophthalmol Scand. 2004 Apr;82(2):161-5.PMID: 15043534 [PubMed - indexed for MEDLINE]Related articles

Comparison of twice-daily and three-times-daily dosing of dorzolamide in ocular hypertension and primary open-angle glaucoma patients treated with latanoprost.

Lupinacci AP, Netland PA, Fung KH, Evans D, Zhao Y.

Adv Ther. 2008 Mar;25(3):231-9.PMID: 18369537 [PubMed - indexed for MEDLINE]Related articles

Twelve-month evaluation of brimonidine-purite versus brimonidine in patients with glaucoma or ocular hypertension.

Katz LJ.

J Glaucoma. 2002 Apr;11(2):119-26.PMID: 11912359 [PubMed - indexed for MEDLINE]Related articles

Comparison of the efficacy and safety of dorzolamide 2% when added to brimonidine 0.2% or timolol maleate 0.5% in patients with primary open-angle glaucoma.

Oztürk F, Ermiş SS, Inan UU, Aşagidag A, Yaman S.

J Ocul Pharmacol Ther. 2005 Feb;21(1):68-74.PMID: 15718830 [PubMed - indexed for MEDLINE]Related articles

Brimonidine 0.2% vs unoprostone 0.15% both added to timolol maleate 0.5% given twice daily to patients with primary open-angle glaucoma or ocular hypertension.

Sharpe ED, Henry CJ, Mundorf TK, Day DG, Stewart JA, Jenkins JN, Stewart WC.

Eye (Lond). 2005 Jan;19(1):35-40.PMID: 15094733 [PubMed - indexed for MEDLINE]Related articles